WNS (Holdings) Limited (NYSE:WNS) Q3 2020 Earnings Conference Call January 16, 2020 8:00 AM ET Company Participants David Mackey – Executive Vice President of Finance & Head of Investor Relations Keshav Murugesh – Chief Executive Officer Sanjay Puria – Chief Financial Officer Gautam Barai – Chief Operating Officer Conference CallRead More →
When the 180-day lockup period for Afya Ltd. (AFYA) ends on January 15, 2020, pre-IPO shareholders and company insiders will be able to sell more than 13 million currently-restricted shares in the secondary market. With just 13.7 million shares trading pursuant to the IPO, any significant sales could flood theRead More →
NovoCure Limited (NASDAQ:NVCR) is a ~$7.9 billion market capitalization oncology device company that provides patients with a new cancer treatment based on alternating electric field technology. The company’s lead product is based on the research work of founder Yoram Palti that such electric fields, when applied at specific frequencies, canRead More →
Third Point was founded in 1995 by Daniel S. Loeb, who serves as Chief Executive Officer. Third Point focuses on event-driven, value-oriented investing. Third Point’s Offshore Fund lost ‐0.2% during the Third Quarter of 2019 and returned +12.7% through September 30, 2019. For the year through Q3 2019, our RoARead More →
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Dan Loeb’s Third Point Portfolio series to getRead More →
iClick Interactive Asia Group Limited (NASDAQ:ICLK) Q3 2019 Results Conference Call November 26, 2019 8:00 AM ET Company Participants Lisa Li – Senior Manager, IR Sammy Hsieh – CEO and Co-Founder Dr. Jian Tang – COO, CTO and Co-Founder Terence Li – CFO Conference Call Participants Long Lin – TheRead More →
Elevator Pitch I like Hong Kong-listed automobile dealer China Yongda Automobiles Services Holdings Limited (OTC:CYYHF) [3669:HK] as a proxy for BMW (OTCPK:BMWYY) sales in China and its growing ancillary businesses. The company’s recent acquisition also helps it increase exposure to key luxury brands and lower-tier cities. China Yongda trades atRead More →
Investment Thesis Downside risk outweighs upside potential after warmer shift in recent model runs. Natural gas winter contracts gap lower after forecast models shifted warmer over the weekend On Monday, the December contract settled lower 12.2 cents ($0.122) to $2.566/MMBtu. Further down the strip, the January contract settled down 12Read More →
National Australia Bank Limited (OTCPK:NABZY) Q4 2019 Results Conference Call November 6, 2019 6:30 PM ET Company Participants Phil Chronican – CEO Gary Lennon – CFO Ross Brown – IR Conference Call Participants Victor German – Macquarie Andrew Lyons – Goldman Brendan Sproules – Citigroup Jarrod Martin – Credit SuisseRead More →
BYD (OTCPK:BYDDF, OTCPK:BYDDY) is a major Chinese Battery Electric Vehicle (BEV) manufacturer. It has had a less-than-glamorous 2019, with a year high of $7.60 and year low of $4.67. It currently trades near the year low at $4.82. As SA author Kwan-Chen Ma commented recently, if you can cope withRead More →
Introduction South32 (OTCPK:SOUHY) (OTCPK:SHTLF) has been one of my favorite commodity companies for a while now and although its share price has quadrupled in the past few years, the company rarely receives the attention it deserves as its operating margins and free cash flow yields remain very high. Source: YahooRead More →
Sibanye Gold (NYSE:SBGL) is the world’s largest producer of platinum, the second-largest producer of palladium, along with a major gold mining operation. The company struggled in recent years given the volatile pricing environment, but has grown through a number of acquisitions including its merger with U.S.-based Stillwater Group in 2016Read More →
On Tuesday, August 20, 2019, ship owner and leasing firm Ship Finance International (SFL) announced its second-quarter 2019 earnings results. At first glance, these results appeared to be rather mixed, as the company did beat the earnings expectations of its analysts by quite a bit, but it also failed toRead More →
Lately, recession signals seem to be popping up daily. Risk averse investors may find it wise to start preparing for the possibility of an economic downturn. Horizon Therapeutics (HZNP) is one option as an equity that is resistant to the business cycle fluctuations and is poised to continue a steadyRead More →
Health-care providers and organizations bear the responsibility for rooting out bias in medical care, experts say. In the meantime, though, there are steps patients can take to shield themselves. Research shows that patients of different genders, colors, sexual orientations and sizes don’t always receive the same quality of care duringRead More →
Chinese Internet giant Tencent (OTCPK:TCEHY) has numerous strengths which should appeal to investors. It is a complex company which I detailed in an article last year. Business services, advertising, and fintech will provide strategic long-term growth based on its massive WeChat platform. Its core gaming platform looks set to re-assertRead More →
Tencent (OTCPK:TCEHY) is a fantastic business with some strong long-term prospects. It has been unfairly caught up in the back and forth of the US-China trade war. However, the near-term trade dispute will not damage the long-term potential of the business. It is a core holding in my Project $1MRead More →
It looks like the gold bull market has finally arrived. Most recently, the spot price of gold has been on a tear, and even managed to hit a high of ~$1,475/oz, before cooling off a bit to settle at around ~$1,462/oz. Now, gold is currently trending back up again, tradingRead More →
Alibaba (BABA) has become the stock of choice for a trade on a resolution to the trade war with China. However, their actions (or lack thereof) have reduced my trust in management. Further, the profitability has been mysteriously declining. I only buy stocks of best of breed stories to increaseRead More →
Introduction The political risks associated with emerging market investments are well known and seldom lost on the minds of most investors, however, a new bipartisan bill from the US Congress will further amplify this risk for PetroChina (PTR). This new legislation would force Chinese companies listed on US stock exchangesRead More →
Fang Holdings Limited (NYSE:SFUN) has been the victim of questionable overreactions of late. Splitting from China Index Holdings Limited (NASDAQ:CIH) was a good move that reduced the company’s annual cash drain by 22.2%, yet the market erroneously saw it as a Sell signal. Despite Q1’s Chinese housing market slump andRead More →
Founded in June 2014, Up Fintech (TIGR), also known as Tiger Brokers, is an online stock brokerage company operating in China. Backed by Interactive Brokers Group Inc. (IEX:IBKR), Xiaomi Inc. (XI), ZhenFund, and Wall Street investment guru Jim Rogers, the company was quite a rising star in the industry andRead More →
CK Hutchison Holdings Ltd. (OTCPK:CKHUF, OTCPK:CKHUY) is an industrial conglomerate headquartered in Hong Kong. However, the European market has surpassed the Asian special administrative zone as the group’s most important geography. I therefore believe that investors should look at the company differently than its more home market-focussed peers. Please note:Read More →
Ongoing tensions between the U.S. and China and unreliable back-and-forth in communication paired with the exit of a large shareholder have triggered a correction in Alibaba’s (BABA) stock price. Source: Alibaba Investor Relations Despite stellar earnings and financials, investors take a much more negative view currently as sentiment is vastlyRead More →
Worldwide investors commit millions of dollars to drug companies, hoping that a new drug will become a blockbuster. However, before committing, investors should consider a thorough scientific due diligence to reduce risk. On May 7th, Actinogen, a small-cap Australian company, announced that their phase-2 trial of Xanamem showed no cognitiveRead More →